OTHER GROUP COMPANIES
market

Nectar Life gets nod for Cephalosporin API: Reports

Report said that the company have Regulatory approvals for majority of Plants.

May 18, 2015 12:29 IST | India Infoline News Service
Nectar Lifesciences has received approval for Cephalosporin API, according to reports.

Report said that the company have Regulatory approvals for Majority Of Plants

The stock was up 3% at Rs. 35.

The stock has hit a high of Rs. 36 and a low of Rs. 34.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity